TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER

Abstract

Gastric cancer is one of the leading causes of death among all cancers in Russia. Progression-free and overall survival cannot be drastically changed by current therapeutic approaches. There is a strong need in new drugs for that disease. Teysuno has demonstrated its efficacy in treatment of advanced gastric cancer and some other cancers. The more drugs we obtain for clinical practice the more opportunities we can offer for these patients.

Keywords

• gastric cancer
• teysuno
• fluoropyrimidines